Published in Healthcare Mergers, Acquisitions and Ventures Week, July 31st, 2004
The company issued no warrants in conjunction with the sale. Adams, Harkness & Hill acted as the placement agent for the financing.
The company plans to use the proceeds for general working capital purposes and to finance the manufacturing of the ATS Open Pivot Valve and its components in the company's own facility. ATS also plans to continue to seek strategic investments in additional products that will leverage its operating platform and expand its presence in the cardiovascular surgery market.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.